Aleksandra Pietruczuk

Aleksandra Pietruczuk

Auto-generated profile, based on publicly available information

Aleksandra Pietruczuk

Department of Neurology, Medical University of Lublin, Lublin, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2025 in American Journal of Case Reports
Verified
Journal Article
Open access
MSMichał Jakub Sekuła
Michał Jakub Sekuła
Anna Jamroz-Wis̈niewskaAnna Jamroz-Wis̈niewska
Anna Jamroz-Wis̈niewska
UCUrszula Chyrchel-Paszkiewicz
Urszula Chyrchel-Paszkiewicz
APAleksandra Pietruczuk
Aleksandra Pietruczuk
ADAleksandra Dembowska
Aleksandra Dembowska
Konrad RejdakKonrad Rejdak
Konrad Rejdak
BACKGROUND Hemophagocytic lymphohistiocytosis (HLH) is a potentially fatal disease that is uncommon among adults. It is characterized by proinflammatory overactivity of the immune system. In infants it is usually hereditary, whereas in adults it is secondary to infection, malignancies, or autoimmune diseases. Clinical features include fever, hepatosplenomegaly, pancytopenia, lymphadenopathy, hypertriglyceridemia, hyperferritinemia, hemophagocytosis, and, rarely in adults, CNS involvement. CASE REPORT We report the case of a 54-year-old man, in whom HLH has been diagnosed, manifesting mainly as neurological signs - increasing spastic paraparesis with sphincter disorder. He had a fever of unestablished etiology for about 1 year. On brain and thoracic spinal cord MRI there were multiple disseminated focal lesions suspected of being demyelination. Neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis were excluded. Treatment with dexamethasone, etoposide, cyclosporine A, and intrathecal methotrexate was used. After a temporary significant improvement in his clinical condition, the patient died 18 months after diagnosis. Our literature review found 37 cases of HLH with neurological symptoms. Only 3 of these cases (and only 1 of them similar to our case) involved clinical and imaging features of demyelinating disease, as in the present case. CONCLUSIONS HLH mimicking demyelinating disorders is rarely encountered clinically. In such a situation, making a diagnosis is extremely difficult and the initiation of appropriate treatment may be delayed, which significantly worsens the prognosis for patients. Increased clinical awareness of HLH should be present in the non-specific course of various diseases, including those with neurological symptoms of unclear origin.